- Home
- PHGE vs CAPS Comparison
PHGE vs CAPS Comparison
Compare PHGE & CAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- CAPS
- Stock Information
- Founded
- PHGE 2015
- CAPS 1987
- Country
- PHGE Israel
- CAPS United States
- Employees
- PHGE N/A
- CAPS N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- CAPS
- Sector
- PHGE Health Care
- CAPS
- Exchange
- PHGE Nasdaq
- CAPS NYSE
- Market Cap
- PHGE 11.0M
- CAPS 9.8M
- IPO Year
- PHGE N/A
- CAPS N/A
- Fundamental
- Price
- PHGE $0.44
- CAPS $1.52
- Analyst Decision
- PHGE Strong Buy
- CAPS
- Analyst Count
- PHGE 1
- CAPS 0
- Target Price
- PHGE $15.00
- CAPS N/A
- AVG Volume (30 Days)
- PHGE 284.6K
- CAPS 75.5K
- Earning Date
- PHGE 08-13-2025
- CAPS 04-02-2025
- Dividend Yield
- PHGE N/A
- CAPS N/A
- EPS Growth
- PHGE N/A
- CAPS N/A
- EPS
- PHGE N/A
- CAPS N/A
- Revenue
- PHGE N/A
- CAPS $43,416,000.00
- Revenue This Year
- PHGE N/A
- CAPS $7.87
- Revenue Next Year
- PHGE N/A
- CAPS N/A
- P/E Ratio
- PHGE N/A
- CAPS N/A
- Revenue Growth
- PHGE N/A
- CAPS N/A
- 52 Week Low
- PHGE $0.34
- CAPS $1.40
- 52 Week High
- PHGE $3.86
- CAPS $16.18
- Technical
- Relative Strength Index (RSI)
- PHGE 43.34
- CAPS N/A
- Support Level
- PHGE $0.43
- CAPS N/A
- Resistance Level
- PHGE $0.48
- CAPS N/A
- Average True Range (ATR)
- PHGE 0.05
- CAPS 0.00
- MACD
- PHGE 0.00
- CAPS 0.00
- Stochastic Oscillator
- PHGE 58.82
- CAPS 0.00
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About CAPS CAPSTONE HOLDING CORP
Capstone Holding Corp is a building products distribution network. The existing network is comprised of Instone, a distributor of thin veneer stone and related masonry products in the United States, serving both residential and commercial construction markets. The company's product offering includes manufactured and natural stone products, supported by a distribution network. The company's current products include stone veneer, landscape stone, and modular masonry fireplaces.